Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endophthalmitis
100%
Methotrexate
100%
Intravitreal Injection
100%
Rabbit Model
100%
Vitritis
50%
Ocular Inflammation
33%
Balanced Salt Solution
33%
Bacterial Endophthalmitis
33%
Day 14
16%
Inflammation
16%
Non-infectious Uveitis
16%
Haze
16%
Intravitreal
16%
Development Risk
16%
Steroid Injection
16%
Histopathologic Study
16%
Safer Alternatives
16%
Staphylococcus Epidermidis (S. epidermidis)
16%
Antimicrobial Activity
16%
Live Bacteria
16%
Infectious Endophthalmitis
16%
Intravitreal Methotrexate
16%
Intact Structure
16%
Pharmacology, Toxicology and Pharmaceutical Science
Intravitreal Administration
100%
Endophthalmitis
100%
Methotrexate
100%
Dexamethasone
100%
Rabbit Model
100%
Vitritis
27%
Inflammation
18%
Balanced Salt Solution
18%
Steroids
18%
Leporidae
9%
Uveitis
9%
Eye Inflammation
9%
Staphylococcus Epidermidis
9%
Antimicrobial Agent
9%
Bacterium
9%
Immunology and Microbiology
Methotrexate
100%
Dexamethasone
100%
Rabbit Model
100%
Inflammation
27%
Steroid
18%
Leporidae
9%
Uveitis
9%
Staphylococcus Epidermidis
9%
Antimicrobial Activity
9%
Antimicrobial Agent
9%
Bacterium
9%
Veterinary Science and Veterinary Medicine
Dexamethasone
100%
Leporidae
100%
Methotrexate
100%
Inflammation
27%
Antimicrobial Agent
9%
Staphylococcus
9%
Antimicrobial Activity
9%